Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

Bullboard Posts

Comment by wesdevrieson Apr 15, 2014 12:31pm

235 Views

Post# 22453229

RE:RE:Safe To Say

That is correct Pennystalker, no leaks; just some of the retail squirming, going down on small volume. Sad to see, but this is the "venture" exchange! TSX & TXSV both taking a beating across the board! Partly due in fact to economic woes coming out of China. Good buying opps in my opinion...was a buyer @ .35-.36

wdv

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario